Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAFV600E

Blood Adv. 2022 Aug 23;6(16):4901-4904. doi: 10.1182/bloodadvances.2022007519.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Disease Susceptibility
  • Histiocytosis, Langerhans-Cell* / genetics
  • Humans
  • Mutation